The gadopiclenol extension for use in infants and neonates offers high-quality MRI contrast enhancement at half the standard gadolinium dose. The FDA has approved an extension of intravenous ...
National survey data show a 35% increase in child mental health conditions since 2016, with one-quarter of households reporting unmet treatment needs.
Nontargeted testing identified 42 PFAS in cord blood, far exceeding the 8 compounds measured by traditional targeted methods, suggesting broader prenatal exposure. Cumulative exposure estimates ...
New research demonstrates that targeted early intervention services improve academic performance and long-term health for children with developmental disabilities. In a Contemporary Pediatrics® ...
Findings from phase 3 SHORE and COAST 2 trials showed amlitelimab met key efficacy end points in moderate to severe atopic dermatitis, supporting planned regulatory submissions. Sanofi announced ...
Effective immediately, the updated US childhood vaccine schedule will reduce the number of recommended vaccines for all children to 11 diseases, down from 18. On January 5, 2026, the CDC updated the ...
FDA approved caplacizumab for pediatric patients ≥12 years with acquired TTP, supported by retrospective data showing 80% remission. The FDA has approved Cablivi (caplacizumab-yhdp; Sanofi) for ...
Daniela Carvalho, MD, explained how the FDA-approved Nexa cochlear implant system may reduce interruptions in hearing for children while reinforcing the need for infection prevention. The Nexa ...
"For infants born to HBs-Ag-negative women: ACIP recommends individual-based decision-making, in consultation with a health care provider, for parents deciding when or if to give the HBV vaccine, ...
A prepandemic NHANES analysis found no significant differences in fruit, vegetable, or overall diet quality between WIC participants and eligible nonparticipants. No significant prepandemic ...
For over 100 years, type 1 diabetes (T1D) has traditionally been diagnosed and treated at the onset of symptomatic hyperglycemia, often accompanied by severe disease, including life-threatening ...
Long-term data show sustained survival, immune recovery, and metabolic correction after lentiviral gene therapy for ADA-SCID, with no vector-related safety events. Lentiviral gene therapy for ADA-SCID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results